Status:

COMPLETED

Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

National Institutes of Health (NIH)

Conditions:

Hypoplastic Left Heart Syndrome

Total Anomalous Pulmonary Venous Return

Eligibility:

All Genders

Up to 29 years

Phase:

NA

Brief Summary

This clinical trial is studying the use of different levels of oxygen exposure during and after cardiopulmonary bypass in eligible infants to learn about its safety during heart surgery. In addition ...

Eligibility Criteria

Inclusion

  • Age less than 30 days of age at time of surgery with need for cardiopulmonary bypass with cardioplegic arrest (with or without deep hypothermic circulatory arrest)
  • Diagnosis with cyanosis at baseline (pre-operative PaO2 of less than 50mmHG) due to:
  • Complete admixture lesion (example: hypoplastic left heart syndrome, total anomalous pulmonary venous return, truncus arteriosus, pulmonary atresia with VSD)
  • Transposition physiology (example: D-Transposition of the great arteries or Double outlet right ventricle with subpulmonary VSD)
  • Right-to-left shunt (example: Tetralogy of Fallot, double outlet right ventricle with subaortic VSD and pulmonary stenosis)

Exclusion

  • Corrected gestation at time of surgery less than 37 weeks
  • Prior cardiac arrest
  • Current or prior history of extracorporeal membrane oxygenation (ECMO) support
  • Current or prior history of needing renal replacement therapy with dialysis
  • Prior cardiac surgery requiring cardiopulmonary bypass
  • Diagnosis of Ebstein's Anomaly
  • Known genetic syndrome other than Trisomy 21 or DiGeorge Syndrome

Key Trial Info

Start Date :

January 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 20 2023

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT04452188

Start Date

January 18 2021

End Date

April 20 2023

Last Update

June 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan

Ann Arbor, Michigan, United States, 48109